Surge was born from the meeting of two minds with a common passion for impactful translational science
Surge’s mission is to deliver accurate predictions
for complication-free surgeries.
Brice Gaudilliere, an expert in human immunology and single-cell omics technologies, and Julien Hedou, an expert in biomedical informatics and machine learning
Brice, a physician scientist and principal investigator, had been applying single-cell omics technologies to study the human immune response to physiological stress (such as surgery) when Julien joined his lab to develop rigorous statistical methods for the analysis of large and complex biological datasets.
They assembled a team with combined expertise and shared values of scientific rigor, patient-centered approaches, value-based care, and translational medicine and accelerated this field, leading to the launch of Surge.
Scientific & clinical board members
In addition to our Board of founders, investors representatives, and independent experts in the field, Surge has a Scientific & Clinical Advisory Board whose mission is to rigorously advance our technology to its fullest potential towards the goal of enabling personalized care
Franck Verdonk, MD, PhD, an Associate Professor of Anesthesiology & Intensive Care at Sorbonne University Chairs the Scientific Board.
Dyani Jones, DMD, MPH, Clinical Associate Professor of Surgery at Stanford University
Brice Gaudilliere, MD, PhD, Associate Professor of Anesthesiology, Perioperative & Pain Medicine at Stanford University.
Who we are
